Have a personal or library account? Click to login
Clinical Practice: Should we radically alter our sedation of critical care patients, Especially given the COVID-19 pandemics? Cover

Clinical Practice: Should we radically alter our sedation of critical care patients, Especially given the COVID-19 pandemics?

Open Access
|Jan 2021

References

  1. Petty TL. Suspended life or extending death? Chest 1998;114(2):360–1.
  2. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263–306.
  3. Stollings JL, Thompson JL, Ferrell BA, Scheinin M, Wilkinson GR, Hughes CG, et al. Sedative Plasma Concentrations and Delirium Risk in Critical Illness. Ann Pharmacother 2018;52(6):513–21.
  4. Taskforce DAS, Baron R, Binder A, Biniek R, Braune S, Buerkle H, et al. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline). Ger Med Sci 2015;13:Doc19.
  5. Tonner P. To boldly go where no man has gone before... Intensetimes 2016(26):2–9.
  6. Shehabi Y, Chan L, Kadiman S, Alias A, Ismail WN, Tan MA, et al. Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med 2013;39(5):910–8.
  7. Brochard L. Less sedation in intensive care: the pendulum swings back. Lancet 2010;375(9713):436–8.
  8. Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. New England Journal of Medicine 2000;342:1471–7.
  9. Strom T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 2010;375(9713):475–80.
  10. Kauppila T, Kemppainen P, Tanila H, Pertovaara A. Effect of systemic medetomidine, an alpha-2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 1991;74:3–8.
  11. Dollery CT, Davies DS, Draffan GH, Dargie HJ, Dean CR, Reid JL, et al. Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther 1976;19(1):11–7.
  12. Venn RM, Newman PJ, Grounds RM. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Medicine 2003;29:201–7.
  13. Strom T, Stylsvig M, Toft P. Long-term psychological effects of a no-sedation protocol in critically ill patients. Crit Care 2011 ;15(6):R293.
  14. Olsen HT, Nedergaard HK, Strom T, Oxlund J, Wian KA, Ytrebo LM, et al. Nonsedation or Light Sedation in Critically Ill, Mechanically Ventilated Patients. N Engl J Med 2020;382(12):1103–11.
  15. Pichot C, Ghignone M, Quintin L. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J Intensive Care Med 2012;27(4):219–37.
  16. Shehabi Y, Botha JA, Ernest D, Freebairn RC, Reade M, Roberts BL, et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Critical Care and Shock 2010;13:40–50.
  17. Pichot C, Longrois D, Ghignone M, Quintin L. Dexmédetomidine et clonidine : revue de leurs propriétés pharmacodynamiques en vue de définir la place des agonistes alpha-2 adrénergiques dans la sédation en réanimation. Annales Francaises d Anesthesie et de Reanimation 2012;31(11):876–96.
  18. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13(3):260–8.
  19. Burton AC. Physiology and biophysics of the circulation: an introductory text. Chicago: Year Book Medical Publisher; 1972.
  20. Karemaker JM. An introduction into autonomic nervous function. Physiol Meas 2017;38(5):R89–R118.
  21. Petitjeans F, Pichot C, Ghignone M, Quintin L. Early severe acute respiratory distress syndrome: What’s going on? Part II: controlled vs. spontaneous ventilation? Anaesthesiol Intensive Ther 2016;48(5):339–51.
  22. De Robertis E, Longrois D. To streamline the guideline challenge: The European Society of Anaesthesiology policy on guidelines development. Eur J Anaesthesiol 2016;33(11):794–9.
  23. Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Medicine 1997;23(8):893–5.
  24. Moritz RD, Machado FO, Pinto EP, Cardoso GS, Nassar SM. [Evaluate the clonidine use for sedoanalgesia in intensive care unit patients under prolonged mechanical ventilation]. Rev Bras Ter Intensiva 2008;20(1):24–30. Avaliacao do uso da clonidina para sedoanalgesia de pacientes sob ventilacao mecanica prolongada, internados em unidade de terapia intensiva.
  25. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Critical Care 2010;14(2):R38.
  26. Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation 2013;127(15):1576–84.
  27. Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, et al. Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial. JAMA 2017;317(13):1321–8.
  28. Aso S, Matsui H, Fushimi K, Yasunaga H. Dexmedetomidine and mortality from sepsis requiring mecanical ventilation: a japanese nationwide retrospective cohort study. Journal of Intensive Care Medicine 2020.
  29. Akada S, Takeda S, Yoshida Y, Nakazato K, Mori M, Hongo T, et al. The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesthesia and Analgesia 2008;107(1):167–70.
  30. Huang Z, Chen YS, Yang ZL, Liu JY. Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure. Internal Medicine 2012;51:2299–305.
  31. Galland C, Sergent B, Pichot C, Ghignone M, Quintin L. Acute iterative bronchospasm and ‘do not re-intubate’ orders: sedation by an alpha-2 agonist combined with noninvasive ventilation. Am J Emerg Med 2015;33(6):857 e3–5.
  32. Tian X, Li H, Ji Z, Zhao S, Sun M. Application of dexmedetomidine sedation in the treatment of continuous state of asthma : a case report. Zhonghua Wei Zhong Bing Ji JIU Yi Xue 2014;26(8):598.
  33. Takasaki Y, Kido T, Semba K. Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma. J Anesth 2009;23(1):147–50.
  34. Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA 2016;315(22):2435–41.
  35. Thille AW, Frat JP. Noninvasive ventilation as acute therapy. Curr Opin Crit Care 2018;24(6):519–24.
  36. Petitjeans F, Quintin L. Non-invasive Failure in de novo acute hypoxemic respiratory failure: high positive end-expiratory pressure-low PS, i.e. ‘inverted’ settings ? Critical Care Medicine 2016;44(11):e1153–e4.
  37. Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009;35(2):282–90.
  38. Pichot C, Mathern P, Khettab F, Ghignone M, Geloen A, Quintin L. Increased pressor response to noradrenaline during septic shock following clonidine? Anaesthesia and Intensive Care 2010;38(4):784–5.
  39. Leroy S, Aladin L, Laplace C, Jalem S, Rosenthal J, Abrial A, et al. Introduction of a centrally anti-hypertensive, clonidine, reduces noradrenaline requirements in septic shock caused by necrotizing enterocolitis American Journal of Emergency Medicine 2017;35(2):e3–377.
  40. Morelli A, Sanfilippo F, Arnemann P, Hessler M, Kampmeier TG, D’Egidio A, et al. The Effect of Propofol and Dexmedetomidine Sedation on Norepinephrine Requirements in Septic Shock Patients: A Crossover Trial. Crit Care Med 2018.
  41. Voituron N, Hilaire G, Quintin L. Dexmedetomidine and clonidine induce long-lasting activation of the respiratory rhythm generator of neonatal mice: possible implication for critical care. Respir Physiol Neurobiol 2012;180(1):132–40.
  42. Bloor BC. Clonidine and other alpha-2 adrenergic agonists : an important new drug class for the perioperative period. Seminars in Anesthesia 1988;7:170-7.
  43. Maze M. Dexmedetomidine : a view point. Drugs 2000;59:269–.
  44. Stahle H. A historical perspective: development of clonidine. Bailliere’s Clinical Anaesthesiology 2000;14(2):236–46.
  45. Ghignone M, Quintin L, Duke PC, Kehler CH, Calvillo O. Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 1986;64:36–42.
  46. Maze M. From Bench to Bedside and Back Again: A Personal Journey with Dexmedetomidine. Anesthesiology 2016;125(3):590–4.
  47. Colin PJ, Hannivoort LN, Eleveld DJ, Reyntjens K, Absalom AR, Vereecke HEM, et al. Dexmedetomidine pharmacodynamics in healthy volunteers: 2. Haemodynamic profile. Br J Anaesth 2017;119(2):211–20.
  48. Davies DS, Wing LMH, Reid JL, Neill E, Tipett P, Dollery CT. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clinical Pharmacology and Therapeutics 1977;21:593–601.
  49. Kooner JS, Peart WS, Mathias CJ. The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension. British Journal of Clinical Pharmacology 1989;28(3):249–55.
  50. Lorez HP, Kiss D, Da Prada M, Haeusler G. Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system. Naunyn-Schmiedeberg’s Arch Pharmacol 1983;323:307–14.
  51. Unnerstall JR, Kopatjic TA, Kuhar MJ. Distribution of alpha-2 agonist binding sites in the rat and human central nervous system : analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related agents. Brain Research Review 1984;7:69–101.
  52. Talley EM, Rosin DL, Lee A, Guyenet PG, Lynch KR. Distribution of alpha 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. JComp Neurol 1996;372(1):111–34.
  53. Sharma A, Gupta L. Clonidine a wonder drug. Inidian Journal of Anesthesia and Analgesia 2019;6(6):2057-62.
  54. Longrois D, Quintin, L. La dexmedetomidine : raisonnement clinique en vue d’une utilisation pour la sedation en reanimation chez l’adulte Le Praticien en Anesthesie-Reanimation 2015;19(3):125–35.
  55. Abrahams VC, Hilton SM, Zbrozyna A. Active muscle vasodilatation produced by stimulation of the brain stem : its significance in the defence reaction. Journal of Physiology (London) 1960;154:491–513.
  56. Ahlquist RP. A study of adrenotropic receptors. American Journal of Physiology 1948;153:586–600.
  57. Rundfeldt LC, Maggioni MA, Coker RH, Gunga HC, Riveros-Rivera A, Schalt A, et al. Cardiac Autonomic Modulations and Psychological Correlates in the Yukon Arctic Ultra: The Longest and the Coldest Ultramarathon. Front Physiol 2018;9:35.
  58. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936;138(3479):32.
  59. Laborit H. La notion de ‘reaction oscillante post agressive’. Therapie 1951;6(4):207–10.
  60. Andrews PJ, Citerio G. Lund Therapy - pathophysiology-based therapy or contrived over-interpretation of limited data? Intensive Care Med 2006;32(10):1461–3.
  61. Mellander S. Comparative studies on the adrenergic neuro-hormonal control of resistance and capacitance blood vessels in the cat. Acta Physiol Scand Suppl 1960;50(176):1–86.
  62. Chippaux C, Carayon A, Rouffilange F, Fabre A, Borjeix L, Lapalle J. Artificial hibernation in war surgery: with reference to its use in Indochina. Presse Med 1954;62(24):504–6. L’hibernation artificielle en chirurgie de guerre: d’apres son emploi actuel en Indochine.
  63. Freeman NE, Shaffer SA, Schecter AE, Holling HE, Marean NE. The Effect of Total Sympathectomy on the Occurrence of Shock from Hemorrhage. J Clin Invest 1938;17(3):359–68.
  64. Wiggers HC, Ingraham RC, et al. Vasoconstriction and the development of irreversible hemorrhagic shock. Am J Physiol 1948;153(3):511–20.
  65. Cannon WB. Voodoo death. American Anthropologist 1942;44(169–181):169.
  66. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013;310(16):1683–91.
  67. Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009;24(5):293–316.
  68. Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early Sedation with Dexmedetomidine in Critically Ill Patients. N Engl J Med 2019.
  69. Miyazaki S, Uchida S, Mukai J, Nishihara K. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion. Psychiatry and Clinical Neuroscience 2004;58(2):138–44.
  70. Huupponen E, Maksimow A, Lapinlampi P, Sarkela M, Saastamoinen A, Snapir A, et al. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiologica Scandinavica 2008;52(2):289–94.
  71. Alexopoulou C, Kondili E, Diamantaki E, Psarologakis C, Kokkini S, Bolaki M, et al. Effects of dexmedetomidine on sleep quality in critically ill patients: a pilot study. Anesthesiology 2014;121(4):801–7.
  72. Issa FG. Effect of clonidine in obstructive sleep apnea. American Review of Respiratory Diseases 1992;145(2 Pt 1):435–9.
  73. Pandharipande PP, Pun B, Herr DI, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients : the MENDS randomized controlled trial. Journal of American Medical Association 2007;298:2644–53.
  74. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. Journal of the American Medical Association 2009;301:489–99.
  75. Mirski MA, Lewin JJ, 3rd, Ledroux S, Thompson C, Murakami P, Zink EK, et al. Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Med 2010;36(9):1505–13.
  76. Calvillo O, Ghignone M. Presynaptic effect of clonidine on unmyelinated afferent fibers in the spinal cord of the cat. Neuroscience Letters 1986;64:335–9.
  77. Hood DD, Mallak KA, Eisenach JC, Tong C. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. Anesthesiology 1996;85(2):315–25.
  78. Harron DW, Riddell JG, Shanks RG. Effects of azepexole and clonidine on baroreceptor-mediated reflex bradycardia and physiological tremor in man British Journal of Clinical Pharmacology 1985;20:431–6.
  79. Tremblay LE, Bedard PJ. Effect of clonidine on motoneuron excitability in spinalised rats. Neuropharmacology 1986;25:41–6.
  80. Bailey PL, Sperry RJ, Johnson GK, Eldredge SJ, East KA, East TD, et al. Respiratory effects of clonidine alone and combined with morphine, in humans. Anesthesiology 1991;74(1):43–8.
  81. Pichot C, Picoche A, Saboya-Steinbach M, Rousseau R, de Guys J, Lahmar M, et al. Combination of clonidine sedation and spontaneous breathing-pressure support upon acute respiratory distress syndrome : a feasability study in four patients. Acta Anaesthesiologica Belgica 2012;63(3):127–33.
  82. Saito J, Amanai E, Hirota K. Dexmedetomidine-treated hyperventilation syndrome triggered by the distress related with a urinary catheter after general anesthesia: a case report. JA Clin Rep 2017;3(1):22.
  83. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 2012;307(11):1151–60.
  84. Zhang Z, Chen K, Ni H, Zhang X, Fan H. Sedation of mechanically ventilated adults in intensive care unit: a network meta-analysis. Sci Rep 2017;7:44979.
  85. Lindgren BR, Ekstrom T, Andersson RGG. The effects of inhaled clonidine in patients with asthma. American Review of Respiratory Diseases 1986;134:266–9.
  86. Koutsoukou A, Armaganidis A, Stavrakaki-Kallergi C, Vassilakopoulos T, Lymberis A, Roussos C, et al. Expiratory flow limitation and intrinsic positive end-expiratory pressure at zero positive end-expiratory pressure in patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 2000;161(5):1590–6.
  87. Tobias JD. Dexmedetomidine : applications in pediatric ciritical care and pediatric anesthesiology. Pediatric Critical Care Medicine 2007;2007:115–31.
  88. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992;77(6):1125–33.
  89. Galland C, Ferrand FX, Cividjian A, Sergent A, Pichot C, Ghignone M, et al. Swift recovery of severe hypoxemic pneumonia upon morbid obesity. Acta Anaesthesiologica Belgica 2014;65:109–17.
  90. Petitjeans F, Leroy S, Pichot C, Geloen A, Ghignone M, Quintin L. Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome? Temperature (Austin) 2018;5(3):224–56.
  91. Quintin L, Viale JP, Annat G, Hoen JP, Butin E, Cottet-Emard JM, et al. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology 1991;74(2):236–41.
  92. Liatsi D, Tsapas B, Pampori S, Tsagourias M, Pneumatikos I, Matamis D. Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med 2009;35(2):275–81.
  93. Takahashi H, Nishikawa T, Mizutani T, Handa F. Oral clonidine premedication decreases energy expenditure in human volunteers. Can J Anaesth 1997;44(3):268–72.
  94. Mokhtari M, Sistanizad M, Farasatinasab M. Antipyretic Effect of Clonidine in Intensive Care Unit Patients: A Nested Observational Study. J Clin Pharmacol 2017;57(1):48–51.
  95. Kernan S, Rehman S, Meyer T, Bourbeau J, Caron N, Tobias JD. Effects of dexmedetomidine on oxygenation during one-lung ventilation for thoracic surgery in adults. Journal of Minimal Access Surgery 2011;7:227–31.
  96. Huang SQ, Zhang J, Zhang XX, Liu L, Yu Y, Kang XH, et al. Can Dexmedetomidine Improve Arterial Oxygenation and Intrapulmonary Shunt during One-lung Ventilation in Adults Undergoing Thoracic Surgery? A Meta-analysis of Randomized, Placebo-controlled Trials. Chin Med J (Engl) 2017;130(14):1707–14.
  97. But AK, Ozgul U, Erdil F, Gulhas N, Toprak HI, Durmus M, et al. The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 2006;50(10):1207–12.
  98. Nathan AT, Marino BS, Hanna B, Nicolson SC. Novel use of dexmedetomidine in a patient with pulmonary hypertension. Paediatric Anaesthesia 2008;18(8):782–4.
  99. Toyama H, Wagatsuma T, Ejima Y, Matsubara M, Kurosawa S. Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine. International Journal of Obstetrical Anesthesia 2009;18(3):262–7.
  100. Ghignone M, Calvillo O, Quintin L, Noe C, Caple S. Clonidine : a new pulmonary vasodilator. Critical Care Medicine 1986;14:344.
  101. Clementy J, Castagne D, Wicker P, Dallochio M, Bricaud H. Study of the electrophysiologic properties of clonidine administered intravenously. Journal of Cardiovascular Pharmacology 1986;8 (suppl 8):S24–S9.
  102. Ling X, Zhou H, Ni Y, Wu C, Zhang C, Zhu Z. Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials. PLoS One 2018;13(3):e0193303.
  103. Stefanadis C, Manolis A, Dernellis J, Tsioufis C, Tsiamis E, Gavras I, et al. Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction. J Hum Hypertens 2001;15(9):635–42.
  104. Giles TD, Iteld BJ, Mautner RK, Rognoni PA, Dillenkoffer RL. Short-term effects of intravenous clonidine in congestive heart failure. Clinical Pharmacology and Therapeutics 1981;30:724–8.
  105. Hermiller JB, Magorien RD, Leithe ME, Unverferth DV, Leier CV. Clonidine in congestive heart failure : a vasodilator with negative inotropic effects. American Journal of Cardiology 1983;51:791–5.
  106. Olivari MT, Levine TB, Cohn JN. Acute hemodynamic and hormonal effects of central vs. peripheral sympathetic inhibition in patients with congestive heart failure. Journal of Cardiovascular Pharmacology 1986;8:973–8.
  107. Manolis AJ, Olympios C, Sifaki M, Handanis S, Bresnahan M, Gavras I, et al. Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy. Hypertension 1995;26(5):719–24.
  108. Aars H. Effects of clonidine on aortic diameter and aortic baroreceptor activity. European Journal of Pharmacology 1972;20:52–9.
  109. Motz W, Ippisch R, Strauer BE. The role of clonidine in hypertensive heart disease. Influence on myocardial contractility and left ventricular afterload. Chest 1983;83 (suppl):433–5.
  110. Heusch G, Schipke J, Thamer V. Clonidine prevents the sympathetic initiation and aggravation of poststenotic myocardial ischemia. Journal of Cardiovascular Pharmacology 1985;7:1176–82.
  111. Zochowski RJ, Lada W. Intravenous clonidine in acute myocardial infarction in men. International Journal of Cardiology 1984;6:189–201.
  112. Quintin L, Cicala R, Kent M, Thomsen B. Effect of clonidine on myocardial ischemia : a double-blind pilot trial. Canadian Journal of Anesthesia 1993;40:85–6.
  113. Schraub P, Vecchi M, Matthys M, Lecomte B, Ferrara N, Ghignone M, et al. A centrally acting antihypertensive, clonidine, combined to a venous dilator, nitroglycerin, to handle severe pulmonary edema. American Journal of Emergency Medicine 2016;34(3):676.
  114. Geloen A, Pichot C, Leroy S, Julien C, Ghignone M, May CN, et al. Pressor Response to Noradrenaline in the Setting of Septic Shock: Anything New under the Sun-Dexmedetomidine, Clonidine? A Minireview. Biomed Res Int 2015;2015:863715.
  115. Esler M, Dudley F, Jennings G, Debinski H, Lambert G, Jones P, et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 1992;116(6):446–55.
  116. Singhal S, Baikati KK, Jabbour, II, Anand S. Management of refractory ascites. Am J Ther 2012;19(2):121–32.
  117. Lenaerts A, Codden T, Meunier JC, Henry JP, Ligny G. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology 2006;44(4):844–9.
  118. Herr DL, Sum-Ping ST, England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003;17(5):576–84.
  119. Liepert DJ, Townsend GE. Improved hemodynamic and renal function with clonidine in coronary artery bypass grafting. Anesthesia and Analgesia 1990;70:S240.
  120. Kulka PJ, Tryba M, Zenz M. Preoperative alpha-2 adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery : results of a randomized, controlled trial. Critical Care Medicine 1996;24:947–52.
  121. Tasdogan M, Memis D, Sut N, Yuksel M. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth 2009;21(6):394–400.
  122. Chen C, Huang P, Lai L, Luo C, Ge M, Hei Z, et al. Dexmedetomidine improves gastrointestinal motility after laparoscopic resection of colorectal cancer: A randomized clinical trial. Medicine (Baltimore) 2016;95(29):e4295.
  123. Belhoula M, Ciebiera JP, De La Chapelle A, Boisseau N, Coeurveille D, Raucoules-Aime M. Clonidine premedication improves metabolic control in type 2 diabetic patients during ophthalmic surgery. Br J Anaesth 2003;90(4):434–9.
  124. von Dossow V, Baehr N, Moshirzadeh M, von Heymann C, Braun JP, Hein OV, et al. Clonidine attenuated early proinflammatory response in T-cell subsets after cardiac surgery. Anesth Analg 2006;103(4):809–14.
  125. Li B, Li Y, Tian S, Wang H, Wu H, Zhang A, et al. Anti-inflammatory Effects of Perioperative Dexmedetomidine Administered as an Adjunct to General Anesthesia: A Meta-analysis. Sci Rep 2015;5:12342.
  126. Ueki M, Kawasaki T, Habe K, Hamada K, Kawasaki C, Sata T. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia 2014;69(7):693–700.
  127. Xu B, Makris A, Thornton C, Ogle R, Horvath JS, Hennessy A. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. J Hypertens 2006;24(5):915–22.
  128. Quenot JP, Ladoire S, Devoucoux F, Doise JM, Cailliod R, Cunin N, et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med 2007;35(9):2031–6.
  129. Payen JF, Bru O, Bosson JL, Lagrasta A, Novel E, Deschaux I, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Critical Care Medicine 2001;29:2258–63.
  130. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001;29(7):1370–9.
  131. Sauder P, Andreoletti M, Cambonie G, Capellier G, Feissel M, Gall O, et al. Sedation and analgesia in intensive care. French Critical Care Society. Annales Francaises d Anesthesie et de Reanimation 2008;27:541–51.
  132. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84(2):482–92.
  133. Task force of the European Society of C, the North American Society of P, Electrophysiology. Heart rate variability : standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043–65.
  134. Cataldo A, Bianco A, Paoli A, Cerasola D, Alagna S, Messina G, et al. Resting sympatho-vagal balance is related to 10 km running performance in master endurance athletes. Eur J Transl Myol 2018;28(1):7051.
  135. Pichot C, Petitjeans F, Ghignone M, Quintin L. Is there a place for pressure support ventilation and high end-expiratory pressure combined to alpha-2 agonists early in severe diffuse acute respiratory distress syndrome ? Medical Hypotheses 2013;80(6):732–7.
  136. Pichot C, Petitjeans F, Ghignone G, Quintin L. Spontaneous ventilation-high PEEP upon severe ARDS : an erratum to further the analysis. Medical Hypotheses 2013;81(5):966–7.
  137. Petitjeans F, Pichot C, Ghignone M, Quintin L. Building on the Shoulders of Giants: Is the use of Early Spontaneous Ventilation in the Setting of Severe Diffuse Acute Respiratory Distress Syndrome Actually Heretical? Turk J Anaesthesiol Reanim 2018;46(5):339–47.
  138. Petitjeans F, Martinez J, Danguy des Deserts M, Leroy S, Quintin L, Escarment J. A centrally acting antihypertensive, clonidine, sedates patients presenting with acute res-piratory distress syndrome evoked by SARS-coronavirus 2. Critical Care Medicine 2020;in press.
  139. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. Microcirculatory alterations: potential mechanisms and implications for therapy. Ann Intensive Care 2011;1(1):27.
  140. Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 2015;19 Suppl 3:S8.
  141. Pichot C, Geloen A, Ghignone M, Quintin L. Alpha-2 agonists to reduce vasopressor requirements in septic shock? Medical Hypotheses 2010;75:652–6.
  142. Spanagel R. Aberrant choice behavior in alcoholism. Science 2018;360(6395):1298–9.
  143. Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 2004;164(13):1405–12.
  144. Vourc’h M, Feuillet F, Mahe PJ, Sebille V, Asehnoune K, group Bt. Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial. Trials 2016;17(1):415.
  145. Toader E, Cividjian A, Rentero N, McAllen RM, Quintin L. Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings. Journal of Hypertension 2008;26(6):1169–80.
  146. Schlager E, Meier T. A strange Balinese method of inducing sleep with some notes about balyans. Acta Trop 1947;4(2):127–34.
  147. Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P. Clonidine: a new antihypertensive agent. American Journal of Cardiology 1971;28(1):74–83.
  148. Nobrega AC, O’Leary D, Silva BM, Marongiu E, Piepoli MF, Crisafulli A. Neural regulation of cardiovascular response to exercise: role of central command and peripheral afferents. Biomed Res Int 2014;2014:478965.
  149. Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, et al. Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med 2005;11(5):562–6.
  150. Connor DF, Findling RL, Kollins SH, Sallee F, Lopez FA, Lyne A, et al. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attentiondeficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs 2010;24(9):755–68.
  151. White PF. What are the advantages of non-opioid analgesic techniques in the management of acute and chronic pain? Expert Opin Pharmacother 2017;18(4):329–33.
  152. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, Jr., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291(14):1753–62.
  153. Constantin JM, Godet T, James A, Monsel A. A small step for sedation that may become a giant leap for critical care medicine. Anaesth Crit Care Pain Med 2019;38(5):425–7.
  154. Wu XH, Cui F, Zhang C, Meng ZT, Wang DX, Ma J, et al. Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit: A Pilot Randomized Controlled Trial. Anesthesiology 2016;125(5):979–91.
  155. Bourne RS, Mills GH, Minelli C. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial. Crit Care 2008;12(2):R52.
  156. Jaiswal SJ, McCarthy TJ, Wineinger NE, Kang DY, Song J, Garcia S, et al. Melatonin and sleep in preventing hospitalized delirium: A randomized clinical trial(,,,,). Am J Med 2018.
  157. Triltsch AE, Welte M, von HP, Grosse J, Genahr A, Moshirzadeh M, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study. Critical Care Medicine 2002;30:1007–14.
  158. Jozwiak M, Hamzaoui O, Monnet X, Teboul JL. Fluid resuscitation during early sepsis: a need for individualization. Minerva Anestesiol 2018;84(8):987–92.
  159. Hamzaoui O, Teboul JL. Importance of diastolic arterial pressure in septic shock: PRO. J Crit Care 2019;51:238–40.
  160. Geloen A, Chapelier K, Cividjian A, Dantony E, Rabilloud M, May CN, et al. Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study. Crit Care Med 2013;41(12):e431–8.
  161. Lankadeva YR, Booth LC, Kosaka J, Evans RG, Quintin L, Bellomo R, et al. Clonidine Restores Pressor Responsiveness to Phenylephrine and Angiotensin II in Ovine Sepsis. Crit Care Med 2015;43(7):e221–9.
  162. Cioccari L, Luethi N, Bailey M, Shehabi Y, Howe B, Messmer AS, et al. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial. Crit Care 2020;24(1):441.
  163. Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 2012;185(10):1088–95.
  164. Clemmer TP, Fisher CJ, Jr., Bone RC, Slotman GJ, Metz CA, Thomas FO. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1992;20(10):1395–401.
  165. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002;360(9343):1395–6.
  166. Miyamoto K, Nakashima T, Shima N, Kato S, Ueda K, Kawazoe Y, et al. Effect of Dexmedetomidine on Lactate Clearance in Patients with Septic Shock: A Sub-Analysis of a Multicenter Randomized Controlled Trial. Shock 2017;50(2):162-6.
  167. De Kock M, Laterre PF, Van Obbergh L, Carlier M, Lerut J. The effects of intraoperative intravenous clonidine on fluid requirements, hemodynamic variables, and support during liver transplantation : a prospective, randomized study. Anesthesia and Analgesia 1998;86:468–76.
  168. Kulka PJ, Tryba M, Reimer T, Weisser H. Clonidine prevents tissue-malperfusion during extracorporal circulation. Anesthesia and Analgesia 1996;82:S254.
  169. Quenot JP, Binquet C, Pavon A. Cardiovascular collapse: lack of understanding or failure to anticipate heart-lung interaction? . Reanimation (Paris) 2012;21:710–4.
  170. Monnet X, Teboul JL. Passive leg raising. Intensive Care Med 2008;34(4):659–63.
  171. Vieillard-Baron A, Evrard B, Repesse X, Maizel J, Jacob C, Goudelin M, et al. Limited value of end-expiratory inferior vena cava diameter to predict fluid responsiveness impact of intra-abdominal pressure. Intensive Care Med 2018;44(2):197–203.
  172. Vieillard-Baron A, Chergui K, Rabiller A, Peyrouset O, Page B, Beauchet A, et al. Superior vena caval collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med 2004;30(9):1734–9.
  173. Chatterjee K. The fear of beta-blocker therapy in heart failure: time to forget. Arch Intern Med 2004;164(13):1370–1.
  174. Permutt S. Circulatory effects of weaning from mechanical ventilation: the importance of transdiaphragmatic pressure. Anesthesiology 1988;69(2):157–60.
  175. Persichini R, Silva S, Teboul JL, Jozwiak M, Chemla D, Richard C, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med 2012;40(12):3146–53.
  176. Page B, Vieillard-Baron A, Beauchet A, Aegerter P, Prin S, Jardin F. Low stretch ventilation strategy in acute respiratory distress syndrome: eight years of clinical experience in a single center. Crit Care Med 2003;31(3):765–9.
  177. Chanques G, Jaber S, Jung B, Payen JF. Sédation-analgésie en réanimation de l’adulte. Encyclopedie Medico-Chirurgicale, Anesthésie Reanimation 2013;10(4):1–12.
  178. Wrigge H, Downs JB, Hedenstierna G, Putensen C. Paralysis during mechanical ventilation in acute respiratory distress syndrome: back to the future? Crit Care Med 2004;32(7):1628-9; author reply 9–30.
  179. Slutsky AS, Villar J. Early Paralytic Agents for ARDS? Yes, No, and Sometimes. N Engl J Med 2019;380(21):2061–3.
  180. National Heart L, Blood Institute PCTN, Moss M, Huang DT, Brower RG, Ferguson ND, et al. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med 2019;380(21):1997–2008.
  181. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107–16.
  182. Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159–68.
  183. Dellamonica J, Lerolle N, Sargentini C, Hubert S, Beduneau G, Di Marco F, et al. Effect of different seated positions on lung volume and oxygenation in acute respiratory distress syndrome. Intensive Care Med 2013;39(6):1121–7.
  184. Flacke JW, Bloor BC, Flacke WE, Wong D, Dazza S, Stead SW, et al. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 1987;67:11–9.
  185. Pichot C, Petitjeans F, Ghignone G, Quintin L. Commentary : Spontaneous ventilation in the setting of early severe stabilized ARDS: heresy? Austin Journal of Pulmonary and Respiratory Medicine 2016;3(2):1046 (1–8).
  186. Vallee F, Vallet B, Mathe O, Parraguette J, Mari A, Silva S, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008;34(12):2218–25.
  187. Mekontso DA, Charron C, Devaquet J, Aboab J, Jardin F, Brochard L, et al. Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome. Intensive Care Med 2009;35(11):1850–8.
  188. Jozwiak M, Silva S, Persichini R, Anguel N, Osman D, Richard C, et al. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med 2013;41(2):472–80.
  189. Brodsky JB, Bravo JJ. Acute postoperative clonidine withdrawal syndrome. Anesthesiology 1976;44(6):519–20.
  190. Arndts D. New aspects of the clinical pharmacology of clonidine. Chest 1983;83(2 Suppl):397–400.
  191. Gagnon DJ, Riker RR, Glisic EK, Kelner A, Perrey HM, Fraser GL. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study. Pharmacotherapy 2015;35(3):251–9.
  192. Quintin L, Ghignone M. Risks associated with perioperative use of alpha-2 adrenoceptors agonists. In: Scholz J, Tonner PH, editors. Alpha-2 adrenoceptor agonists in anaesthesia and intensive care. London: Harcourt; 2000. p. 347–68.
  193. Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, Mathias CJ. Upregulation of beta adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clinical Autonomic Research 1992;2:165–70.
  194. Robertson D, Goldberg MR, Hollister AS, Wade D, Robertson RM. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. American Journal of Medicine 1983;74(2):193–200.
  195. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Medicine 2004;30:2188–96.
  196. Ingersoll-Weng E, Manecke GRTPA. Dexmedetomidine and cardiac arrest. Anesthesiology 2004;100:738–9.
  197. Hui C, Cardinale M, Yegneswaran B. Significant Bradycardia in Critically Ill Patients Receiving Dexmedetomidine and Fentanyl. Case Rep Crit Care 2017;2017:4504207.
  198. Deletombe B, Trouve-Buisson T, Godon A, Falcon D, Giorgis-Allemand L, Bouzat P, et al. Dexmedetomidine to facilitate noninvasive ventilation after blunt chest trauma: A randomised, double-blind, crossover, placebo-controlled pilot study. Anaesth Crit Care Pain Med 2019;38(5):477–83.
  199. Sartini C, Tresoldi M, Scarpellini P, Tettamanti A, Carco F, Landoni G, et al. Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit. JAMA 2020.
  200. Carrasco G, Baeza N, Cabre L, Portillo E, Gimeno G, Manzanedo D, et al. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial. Crit Care Med 2016;44(7):1295–306.
  201. Lichtfield NB. Complications of intravenous diazepam: respiratory depression (an assessment of 16 000 cases). Anesthesia Progress 1981;29(1):11–7.
  202. Benhamou D, Veillette Y, Narchi P, Ecoffey C. Ventilatory effects of premedication with clonidine. Anesthesia and Analgesia 1991;73:799–803.
  203. Kruger BD, Kurmann J, Corti N, Spahn DR, Bettex D, Rudiger A. Dexmedetomidine-Associated Hyperthermia: A Series of 9 Cases and a Review of the Literature. Anesth Analg 2017;125(6):1898–906.
  204. Myers RD, Beleslin DB, Rezvani AH. Hypothermia: role of alpha 1- and alpha 2-noradrenergic receptors in the hypothalamus of the cat. Pharmacol Biochem Behav 1987;26(2):373–9.
  205. Madden CJ, Tupone D, Cano G, Morrison SF. alpha2 Adrenergic receptor-mediated inhibition of thermogenesis. J Neurosci 2013;33(5):2017–28.
  206. Ma H, Tang J, White PF, Wender RH, Leverone T, Quon R, et al. The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification. Anesth Analg 2003;96(5):1409–12, table of contents.
  207. Bear R, Steer K. Pseudo-obstruction due to clonidine. British Medical Journal 1976;1(6003):197.
  208. Stieger DS, Cantieni R, Frutiger A. Acute colonic pseudoob-struction (Ogilvie’s syndrome) in two patients receiving high dose clonidine for delirium tremens. Intensive Care Medicine 1997;23(7):780–2.
  209. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988;150(12):9–14.
  210. Wing LM, Reid JL, Davies DS, Dargie HJ, Dollery CT. Apparent resistance to hypotensive effect of clonidine. British Medical Journal 1977;1(6054):136–8.
  211. Frisk-Holmberg M, Paalzow L, Wibell L. Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man. Eur J Clin Pharmacol 1984;26(3):309-13.
  212. Erkonen G, Lamb F, Tobias JD. High-dose dexmedetomidine-induced hypertension in a child with traumatic brain injury. Neurocritical Care 2008;9(3):366–9.
  213. Lonnqvist PA, Bergendahl HT, Eksborg S. Pharmacokinetics of clonidine after rectal administration in children. Anesthesiology 1994;81(5):1097–101.
  214. Liu D, Reade MC, editors. Central alpha-2 adrenoreceptor agonists in intensive care. Annual update in intensive care and emergency medicine 2018; 2018: Springer.
  215. Longrois D, Quintin L. Dexmedetomidine: Superiority trials needed? Anaesth Crit Care Pain Med 2016;35(3):237-8.
  216. Segal IS, Vickery RG, Walton JK, Doze VA, Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha-2 adrenergic receptor. Anesthesiology 1988;69:818–23.
  217. Quintin L, Gonon F, Buda M, Ghignone M, Hilaire G, Pujol JF. Clonidine modulates locus coeruleus metabolic hyperactivity induced by stress in behaving rats. Brain Research 1986;362:366–9.
  218. Guyenet P, Schreihofer AM, Stornetta RL. Regulation of sympathetic tone and arterial pressure by the rostral ventrolateral medulla after depletion of C1 cells in rats. Annals of the New York Academy of Sciences 2001;940:259–69.
  219. Schreihofer AM, Guyenet PG. Role of presympathetic C1 neurons in the sympatholytic and hypotensive effects of clonidine in rats. Am J Physiol Regul Integr Comp Physiol 2000;279(5):R1753–62.
  220. Sun MK, Guyenet P. Effect of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Research 1986;368:1–17.
  221. Parlow J, Viale JP, Annat G, Hughson RL, Quintin L. Spontaneous cardiac baroreflex in humans : comparison with drug-induced responses. Hypertension 1995;25:1058–68.
  222. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. Circulation Research 1969;24:109–21.
  223. DeBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. American Journal of Physiology 1987;253:H680–H9.
  224. Saunier CF, Akaoka H, de La Chapelle B, Charlety PJ, Chergui K, Chouvet G, et al. Activation of brain noradrenergic neurons during recovery from halothane anesthesia : persistence of phasic activation after clonidine. Anesthesiology 1993;79:1072–82.
  225. Servan-Schreiber D, Printz H, Cohen JD. A network model of catecholamine effects : gain, signal-to-noise ratio, and behavior. Science 1990;249:892–5.
  226. Aston-Jones G, Cohen JD. Adaptative gain and the role of the locus coeruleus-norepinephrine system in optimal performance. Journal of Comparative Neurology 2005;493:99–110.
  227. McAllister TW, McDonald BC, Flashman LA, Ferrell RB, Tosteson TD, Yanofsky NN, et al. Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response. Int J Psychophysiol 2011;82(1):107–14.
  228. Snapir A, Posti J, Kentala E, Koskenvuo J, Sundell J, Tuunanen H, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 2006;105(5):902-10; quiz 1069–70.
  229. Katona PG, Barnett GO. Central origin of asymmetry in the carotid sinus reflex. AnnNYAcadSci 1969;156:779-86.
  230. Borst C, Wieling W, van Brederode JF, Hond A, de Rijk LG, Dunning AJ. Mechanisms of initial heart rate response to postural change. AmJPhysiol 1982;243(5):H676–H81.
  231. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002;3(8):655–66.
  232. Prys-Roberts C. Regulation of the circulation. In: Prys-Roberts C, editor. The circulation in anaesthesia : applied physiology and pharmacology. Oxford: Blackwell; 1980. p. 179–207.
  233. Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 2016;42(12):1935–47.
  234. Reade MC, Finfer S. Sedation and delirium in intensive care. N Engl J Med 2014;370(16):1567.
  235. Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose Nocturnal Dexmedetomidine Prevents ICU Delirium: A Randomized, Placebo-controlled Trial. Am J Respir Crit Care Med 2018.
  236. Metz G, Nebel B. Clonidine in severe alcohol withdrawal delirium. Fortschrift Medizin 1983;101:1260–4.
  237. Bohrer H, Bach A, Layer M, Werming P. Clonidine as a sedative adjunct in intensive care. Intensive Care Medicine 1990;16:265–6.
  238. Spies CD, Dubisz N, Neumann T, Blum S, Muller C, Rommelspacher H, et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Critical Care Medicine 1996;24(3):414–22.
  239. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010;38(2):419–27.
  240. Gold MS, Redmond DE, Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1978;2:599–602.
  241. Ghignone M, Calvillo O, Quintin L. Anesthesia and Hypertension : the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology 1987;67:3–10.
  242. Ghignone M, Noe C, Calvillo O, Quintin L. Anesthesia for ophthalmic surgery in the elderly : the effects of clonidine on intraocular pressure, perioperative hemodynamics and anesthetic requirements. Anesthesiology 1988;68:707–16.
  243. Glassman AH, Jackson WK, Walsh BT, Roose SP, Rosenfeld B. Cigarette craving, smoking withdrawal and clonidine. Science 1984;226:864–6.
  244. Gold MS, Pottash AL, Extein I, Kleber HD. Clonidine and opiate withdrawal. Lancet 1980;2(8203):1078–9.
  245. Guinot PG, Spitz A, Berthoud V, Ellouze O, Missaoui A, Constandache T, et al. Effect of opioid-free anaesthesia on postoperative period in cardiac surgery: a retrospective matched case-control study. BMC Anesthesiol 2019;19(1):136.
  246. Quintin L, Bouilloc X, Butin E, Bayon MC, Brudon JR, Levron JC, et al. Clonidine for aortic surgery in hypertensive patients : a double blind controlled randomized study. Anesthesia and Analgesia 1996;83:687–95.
  247. McAllen RM, Spyer KM. The baroreceptor input to cardiac vagal motoneurones. Journal of Physiology 1978;282:365–74.
  248. Westlund KN, Craig AD. Association of spinal lamina I projections with brainstem catecholamine neurons in the monkey. Exp Brain Res 1996;110(2):151–62.
  249. Sato A, Schmidt RF. Somatosympathetic reflexes : afferent fibers, central pathways, discharge characteristics. Physiological Reviews 1973;53:916–47.
  250. Morrison SF, Reis DJ. Reticulospinal vasomotor neurons in the RVL mediate the somatosympathetic reflex. American Journal of Physiology 1989;256:R1084–R97.
  251. Pichot C, Ghignone M, Quintin L. Alpha-2 agonists as first-line sedative agents in hyperammonemia-induced hyperactivity ? . Paediatric Anaesthesia 2013;23(9):878–90.
  252. Davies CT, Neilson JM. Disturbance of heart rhythm during recovery from exercise in man. J Appl Physiol 1967;22(5):943–6.
  253. De Mey JG, Vanhoutte PM. Differences in pharmacological properties of postjunctional alpha-adrenergic receptors among arteries and veins. Arch Int Pharmacodyn Ther 1980;244(2):328–9.
  254. Shimamura K, Toba M, Kimura S, Ohashi A, Kitamura K. Clonidine induced endothelium-dependent tonic contraction in circular muscle of the rat hepatic portal vein. J Smooth Muscle Res 2006;42(2-3):63–74.
  255. Yu T, Huang Y, Guo F, Yang Y, Teboul JL, Qiu H. The effects of propofol and dexmedetomidine infusion on fluid responsiveness in critically ill patients. J Surg Res 2013;185(2):763–73.
DOI: https://doi.org/10.2478/rjaic-2020-0018 | Journal eISSN: 2502-0307 | Journal ISSN: 2392-7518
Language: English
Page range: 43 - 76
Published on: Jan 4, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 D Longrois, F Petitjeans, O Simonet, M de Kock, M Belliveau, C Pichot, Th Lieutaud, M Ghignone, L Quintin, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 License.